Skip to main content
PLOS One logoLink to PLOS One
. 2020 Jul 23;15(7):e0236068. doi: 10.1371/journal.pone.0236068

The economic burden of non-communicable disease mortality in the South Pacific: Evidence from Fiji

Shamal Shivneel Chand 1,#, Baljeet Singh 1,*,#, Sanjesh Kumar 1,#
Editor: Gausal A Khan2
PMCID: PMC7377477  PMID: 32702003

Abstract

Non-communicable diseases (NCDs) have emerged as one of the major endemics in Fiji which is responsible for more than 80 percent of deaths annually. In this study, we estimate the economic burden of non-communicable disease mortality in Fiji. The specific impact of diabetes, cardiovascular disease, chronic respiratory disease and cancer-related mortality on Fiji’s output is also investigated using the autoregressive distributed lag bounds tests approach to cointegration. The data used is compiled from Fiji Ministry of Health and Medical Services and World Health Organization’s Mortality database. Overall, the study finds that NCD mortality rate together with cardiovascular disease, diabetes, chronic respiratory disease and cancer have a significant negative effect on output per capita of Fiji between 1972 and 2016. A one percentage point increase in NCD-mortality rate reduced output per capita by 0.012 percent. In addition, a percentage point increase in the mortality rates of cardiovascular disease, diabetes, chronic respiratory disease and cancer decreased output per capita by 0.018, 0.01, 0.031, and 0.035 percent, respectively. The findings conclude that NCD poses significant economic burden in Fiji and recommend policy innovations in lessening the high risk of NCD among the Fijian population.

Introduction

The prevalence rate for non-communicable diseases (NCDs) in the low and middle-income countries has been growing steadily, presenting a major threat to people, families, and communities while hindering the potential achievement of development goals [1]. Each year, 41 million people die from an NCD of which 15 million people are between ages 30 and 69 [2]. Rising NCD crisis in the low and middle-income countries poses a significant threat to the progress on sustainable development goals especially the poverty reduction strategies. In particular, low income earners and disadvantaged group are more likely to get sick and die from NCDs because of greater risk of getting exposed to behavioural risk factors such as unhealthy diet, and harmful consumption of tobacco and alcohol, which makes households use family income to finance their healthcare cost [3]. The global economic burden of NCD study also reported that NCDs are likely to cause around US$47 trillion in output loss within the next two decades [4].

Despite being a developing nation, Fiji has one of the highest rates of NCDs in the world where it accounts for more than 80 percent of all deaths, of which most are premature [5]. The four major types of NCDs that include cardiovascular diseases (CVD), diabetes mellitus (DM), chronic respiratory disease (CRD) and cancers (CAN) accounts for the largest share with cardiovascular diseases such as heart disease and stroke affecting most number of Fijians [6]. In 2018, Fiji recorded the highest death rate from diabetes compared to any other country with 188 fatalities per 100,000 [7]. The burden of NCD-related deaths on Fiji’s output is under-researched, despite the high rate of NCD prevalence and mortality. Some of studies involving cost-of-illness analysis estimated FJ$8.8 million in cost arising from stroke mortality among young people [8] and approximately FJ$49 million in output loss from rheumatic heart disease related premature mortality annually [9]. These studies have been influential on the cost of NCDs in Fiji; however, they only provide cost estimate of specific type of NCD mortality.

The macroeconomic studies argue that NCDs are detrimental to the level of economic output and growth through the channels of labour and capital accumulation [1012]. Overtime, NCDs will reduce the quality and quantity of a country’s labour force, affecting and lowering the national income. Workers with NCDs are more likely to get regularly sick, which will reduce their efficiency in terms of using machinery and equipment in production whereas NCD mortality will reduce the size of skilled and unskilled labour essential for long run economic growth [13]. Additionally, NCD-related morbidity will reduce the capital stock since savings will be used for the treatment of NCDs instead of investment purposes [4]. While NCD could also indirectly affect the development of human capital when children are required to take care of their sick parents from young age.

NCDs, in particular, diabetes, cardiovascular disease, chronic respiratory disease and cancer are growth-retarding factors. Although the literature shows limited empirical investigation in this area, most of the cost-of-illness studies have concluded that NCDs pose a significant financial burden on the households, individuals, businesses and the whole economy [1418]. The empirical studies that did include NCDs into the growth models have found that it significantly reduced the economic growth and long-run output. For example, Suhrcke and Urban [19] used the GMM one-step system estimation and regressed the gross domestic product (GDP) per capita on its five-year time lag, openness, average years of schooling, investment rate, fertility rate, adult mortality rate and importantly the CVD mortality rate. The study concludes that CVD is detrimental to growth only for countries with a high per capita income or at a threshold income of US$7231. Since NCDs were still lagging behind communicable diseases in developing countries in the year of study, the detrimental effects were not noticeable. However, Suhrcke and Urban [19] argued that as NCDs become more common in the developing countries because of changing lifestyles, its adverse effect on health, income and growth will become more noticeable and common, despite what is the level of per capita income in the country.

Health is a multidimensional concept that cannot be fully measured using a single indicator. Hence, one of the widely used measure for health is the probability of death, which is captured by life expectancy and the infant mortality rate [20]. Other measures of health could be the Disability Adjusted Life Years lost (DALY), which does not only include the measures of mortality but also the measures of morbidity due to an increase in disease incidence. Intelligence, such as the national average intelligence quotient (IQ) and test scores, can also be a measure of health since it falls in the biological aspect of human development and education. Improvement in biological health over time is an indication of improved intelligence and human capital [20]. This study uses the NCD mortality rate as an indicator of health capital to measure its impact on Fiji’s per capita income level.

Despite fewer studies investigating linkages between NCDs and economic growth, a few studies have looked at the relationship between nutritional status and economic output since nutritional status is an important link between NCDs and growth relationship. Using the cointegration approach and Granger causality test, Neeliah and Shankar [21] attempted to derive a short-run and long-run causality between calorie intake and GDP. The study recommends that calorie intake needs to be minimised to reduce the NCD prevalence in the population. A similar study by Dube and Phiri [22] in the context of South Africa found a positive and significant relationship between nutritional intake and economic growth. The estimated coefficient of nutritional intake was 0.15 and the authors found a strong causal effect from nutrition to economic growth.

Theoretically, NCDs will reduce the supply of labour and productivity. As the mental and physical capacity of the worker deteriorates due to NCD morbidity, the level of productivity, efficient use of technology and machinery diminishes [19]. NCD-related morbidity and sickness in the labour force imply that more workers will be out of the work-force to get their treatment while mortality will permanently reduce the size of the skilled labour force [10]. In this context, the firms endure an additional cost of training and hiring new workers for the positions left vacant by workers suffering from a particular type of NCD. Additionally, NCD-related morbidity increases the healthcare cost and decreases capital investment since individuals suffering from NCDs use savings for treatment [10]. It would be rather difficult to factor in all the channels into the model due to the lack of data on morbidity, disability and healthcare cost devoted to NCDs. Two of the studies have used NCD-related mortality rates to measure the impact of NCD on output, particularly Suhrcke and Urban [19] for OECD countries and Frank [23] for a panel of Latin America and Caribbean countries.

Hence, in the spirit of the studies mentioned, this study will also use the NCD mortality rate to measure the impact of NCD on the output of Fiji. Autoregressive Distributed Lag (ARDL) bounds test approach to cointegration is used to examine the relationship. Being one of the first studies in this area for Fiji, the findings will be of utmost importance and relevant to the health and economic sector. The rest of the paper is structured as follows. Section 2 outlines the methods and materials inclusive of model, estimation procedure and data source. The results are discussed in section 3 and lastly, section 4 provides concluding remarks and policy implications.

Methods and materials

We employ the model developed by Bloom, Canning [24] to demonstrate the impact of the NCD mortality rate on Fiji’s output. The model has physical capital, labour, human capital, and health capital and technology as exogenous components in the production function as follows.

Y=AKLβe1hc+2h (1)

where Y is the output, measured by real gross domestic product (RGDP); A is the total factor productivity (TFP); K is the stock of physical capital; and L is the labour force. Bloom, Canning [24] decomposed productivity in terms of human capital (hc) and health status (h). In the model, human capital consisted of three components, namely average years of schooling, average work experience of the work force, and squared average work experience. On the other hand, life expectancy is used as a proxy for health. For the purpose of this analysis, gross secondary school enrolment rate is used as a proxy for human capital [25]. As the objective of this study postulates, mortality rates of aggregate NCD, diabetes, cardiovascular disease, chronic respiratory disease and cancer will be used as the proxy for health status component, similar to the study by Frank [23]. According to Bloom, Canning [24], the functional form as outlined in Eq (1) has an advantage since it replicates the microeconomic studies where wage, as in output in macroeconomics studies, depends on schooling and health status of workers.

The following equations are derived after transforming the model in per capita terms and substituting the secondary school enrolment rate as human capital and NCD mortality rates into health capital.

MajorNCDs:y=Akeθ1SEC+θ2NCD (2)
DecomposedMajorNCDs:y=Akeθ3SEC+θ4DM+θ5CVD+θ6CRD+θ7CAN (3)

where y is output per capita, k is physical capital per capita, and SEC is the gross secondary school enrolment rate in Eqs (2) and (3). NCD mortality rate (NCD) is the proxy for health capital in Eq (2). In Eq (3), DM is diabetes, CVD is cardiovascular disease, CRD is the chronic respiratory disease and CAN is the cancer mortality rate. Hence, we take natural logarithms (ln) of Eqs (2) and (3) to derive the linear forms for estimation as follows.

MajorNCDs:lnyt=at+lnkt+θ1SECt+θ2NCDt+et (4)
DecomposedMajorNCDs:lnyt=at+lnkt+θ1SECt+θ2DMt+θ3CVDt+θ3CRDt+θ4CANt+et (5)

The term e represents the residual in the equations above. We expect both k and SEC to have positive impact on output per capita whereas NCD mortality rates are expected to be negatively related to output. Similar studies in this area by Frank [23] demonstrated that NCD mortality rate has a negative impact on output per capita of Latin America and Caribbean countries. In addition, Suhrcke and Urban [19] also conclude that cardiovascular disease and NCD mortality rates negatively affect the future growth of output per capita, particularly in high-income countries. Models (4) and (5) are estimated using the ARDL bounds test to cointegration technique, and more detail of this approach is outlined in the estimation procedure.

Estimation procedure

The economic theory stipulates that there exists a long-run relationship among the macroeconomic variables when the mean and variances are constant over time and not trended. However, recent years of empirical researches have shown that time-series variables, in particular, have trended mean and variances or are simply non-stationary. Hence, ordinary least squares (OLS) estimates give spurious results that could be disastrous for policymaking.

The non-stationarity problem in the time-series variables usually arise from the presence of unit root or structural breaks, usually dealt with by de-trending or taking the first difference of the variables. Although this allows estimation of short-run dynamics, the long-run information is lost. To solve the issue of non-stationarity among the time-series variables, econometric analysis has moved towards the cointegration method. Cointegration among the variables occurs when two or more time-series variables are related in a way that in the long-run it moves to some steady state equilibrium. The variables need to be integrated of the same order I(d) while the residuals need to be integrated of order one less I(d-1) for the cointegration to occur, according to Engle and Granger (1987). If the variables are cointegrated then it is possible to estimate the long-run equation. On the other hand, if the variables do not cointegrate then the long-run estimation will give spurious regression and it will only be possible to estimate the short-run dynamics.

Granger [26] was the first to suggest the possibility of cointegration among variables in a spurious regression. Engle and Granger [27], autoregressive distributed lag bounds test approach to cointegration [28, 29], and Johansen and Juselius [30] cointegration techniques have largely contributed towards the cointegration literature. Additionally, each of the technique estimates the error correction model to derive the short-run dynamics and correction of disequilibrium in a long-run scenario.

The classical Engle and Granger [27] cointegration technique only allows for cointegration tests to be conducted when the variables are integrated of the same order. For the purpose of this study, autoregressive distributed lag bounds test approach to cointegration by Pesaran, Shin [29] is adopted as an appropriate methodology to investigate the existence of long-run level relationship and derive efficient estimates since some of the time-series variables in the investigation were initially found to be I(1) while other variables were I(0) at level forms. Hence, one of the advantages of the ARDL model is that it is very flexible where variables of both I(0) and I(1) status can be used to test for a cointegrating relationship. Secondly, the ARDL approach is an advantage to studies using a small sample size for estimation and forecasting [31]. Thirdly, the ARDL approach gives a consistent and unbiased estimate of the long-run parameters and each variable can have their own different lag-lengths compared to conventional cointegration tests [32]. The fourth advantage of the ARDL approach is that it adequately deals with the problems of autocorrelation and endogeneity and provides unbiased and super-consistent coefficients with valid t-statistics [3234]. In sum, there are two steps involved in the ARDL bounds test approach to cointegration.

Step 1: Investing the existence of long-run relationship

The calculated F-statistics for bounds test to cointegration determines the existence of a long-run relationship among the variables. The bounds F-statistic is calculated when one of the variables stand as an endogenous variable while others are exogenous. According to Narayan and Smyth [35], if a long-run relationship among the variables is predicted by the ARDL methodology then the error correction regression (Step 2) can be estimated without having any knowledge on the direction of the long-run relationship among the variables. The following general ARDL regression outlines the overall cointegration procedure.

ΔYt=δ0+i=1kα1ΔYti+i=0kα2ΔXti+δ1Yt1+δ2Xt1+vt (6)

The following equation outlines the ARDL regressions for models (4) and (5):

Model 4 ARDL regression

Δlnyt=0+i=1kρ1Δlnyti+i=0kρ2Δlnkti+i=0kρ3ΔSECti+i=0kρ4ΔNCDti+1lnyt1+2lnkt1+3SECt1+4NCDt1+5COUPt+wt (7)

Model 5 ARDL regression

Δlnyt=φ0+i=1kσ2Δlnyti+i=0kσ3Δlnkti+i=0kσ4ΔSECti+i=0kσ5ΔDMti+i=0kσ6ΔCVDti+i=0kσ7ΔCRDti+i=0kσ8ΔCANti+φ1lnyt1+φ2lnkt1+φ3SECt1+φ3DMt1+φ4CVDt1+φ5CRDt1+φ6CANt1+φ7COUPt+xt (8)

In the above ARDL regressions, k is the optimum number of lags selected by the Akaike Information Criterion (AIC). The joint null hypotheses for testing the long-run relationship among the variables in Eqs (7) and (8) are stated as follows: The null hypotheses for testing the long-run relationship are ∅1 = ∅2 = ∅3 = ∅4 = ∅5 = 0 for Eq (7) and φ1 = φ2 = φ3 =φ4 = φ5 = φ6 = φ7 = 0 for Eq (8).

The upper and lower bounds critical values provided by Pesaran, Shin [29] for large sample size and Narayan [31] for small sample size are used for testing existence of a long-run relationship. If the F-statistic lies below the lower bound critical value at 5 percent significance level, the test fails to reject the null hypothesis (no existence of long-run relationship). On the other hand, if the F-statistic lies above the upper bound critical value, the test rejects the null hypothesis. However, in the case of F-statistic falling within the lower and upper bound critical values, the test for cointegration is inconclusive.

Step 2: Estimating the Error Correction Model (ECM)

Time-series variables at level form suffer from non-stationarity problems and one of the ways to deal with non-stationarity is to first difference the variables. However, the estimated equation using the first-differenced variables give short-run parameters while the long-run information is lost. Therefore, the short-run dynamics are not useful in certain ways since the policy-makers and researchers are more interested in the long-run properties. Thus, the error correction models incorporate both the short-run and long-run dynamics.

The general ECM for the ARDL specification can be written in terms of the first difference and lagged level variables form as follows:

ΔYt=δ0+i=1kβiΔYti++γ1ECTt1+εt (9)

The ECTt−1 is the error correction term defined as:

ECTt1=Yt1i=0kθiXi,t1 (10)

The ECM specification (9) is applied to models (4) and (5):

Model 4 ECM

Δlnyt=0+i=1kρ1Δlnyti+i=0kρ2Δlnkti+i=0kρ3ΔSECti+i=0kρ4ΔNCDti+1COUPt+2ECTt1+wt (11)

Model 5 ECM

Δlnyt=φ0+i=1kσ1Δlnyti+i=0kσ2Δlnkti+i=0kσ3ΔSECti+i=0kσ4ΔDMti+i=0kσ5ΔCVDti+i=0kσ6ΔCRDti+i=0kσ7ΔCANti+φ1COUPt+φ2ECTt1+xt (12)

The ECTt−1 is derived as residuals from the cointegrating equation which shows disequilibrium correction between the previous period (t−1) and the current period (t) or the adjustment parameter. The coefficient of ECTt−1 is expected to be negative and should lie between zero and a negative one to show convergence. For example, if the parameter is -0.5 then it shows that 50 percent of the disequilibrium is adjusted within the current period and the model converges to a steady state. A positive parameter indicates model instability and movement away from the steady-state, which has no relevance in policy-making.

Data

Table 1 provides the list of all variables used in the analysis and their data sources. The study uses time-series macroeconomic data from 1972 to 2016. The GDP data is from the World Bank’s development indicators database at constant Fiji dollars while physical capital stock is from the Penn World Tables v9.0. It was important to use real values to remove the influence of inflation for efficient estimations. Output per capita y and capital per capita k is calculated by dividing the aggregate GDP and capital stock with the total population.

Table 1. Data definition, description and sources.

Variables Description Source(s)
y Output per capita. GDP at constant 2010 FJ$ divided by the total population. GDP at constant 2010 FJ$ and the total population was sourced from the World Bank’s database.
k Capital stock per capita. Physical capital stock in constant FJ$ divided by total population. Data for the capital stock is sourced from the Penn World Tables v9.0
DM Diabetes Mellitus mortality rate (%) Fiji Ministry of Health’s Annual Reports and WHO’s Mortality database
CVD Cardiovascular disease mortality rate (%) Fiji MOH’s Annual Reports and WHO’s Mortality database
CRD Chronic Respiratory disease mortality rate (%) Fiji MOH’s Annual Reports and WHO’s Mortality database
CAN Cancer mortality rate (%) Fiji MOH’s Annual Reports and WHO’s Mortality database
NCD Non-communicable diseases mortality rate (%) Fiji MOH’s Annual Reports and WHO’s Mortality database
SEC Secondary School gross enrolment ratio (%). World Bank’s development indicators database
COUP The dummy variable for political instabilities in years 1987, 2000 and 2006. Author’s calculation

The main variables of interest in this study are the mortality rates for NCDs, diabetes, cardiovascular disease, chronic respiratory disease and cancer. The mortality rates were computed by dividing the number of deaths for a particular disease with the total number of deaths in a given year. Data on the number of deaths caused by NCDs were acquired from the Fiji Ministry of Health and Medical Services Annual Reports and World Health Organization’s mortality database with reference to International Classification of Diseases (ICD) 10. After compiling the number of deaths for all major NCDs, it was divided by the total number of deaths in a given year (from 1972–2016) to get the mortality rates.

Table 2 provides a summary and distribution of the main variables used in the analysis from 1972 to 2016. On average, GDP per capita was FJ$6,669.63, capital per capita was FJ$21,759.41 and secondary school enrolment rate was 77.95 percent between 1972 and 2016. While average cardiovascular disease, diabetes, cancer and chronic respiratory disease mortality rates were 36.42, 9.85, 10 and 8.23 percent respectively.

Table 2. Summary statistics from 1972–2016.

Variable Observations Minimum Maximum Mean Std. deviation
Output per capita 45 5103.88 8836.71 6669.63 1022.04
Capital per capita 45 9180.40 40052.34 21759.41 8781.94
SEC (%) 45 58.85 91.01 77.95 8.56
CVD (%) 45 23.03 49.24 36.42 5.00
DM (%) 45 1.76 23.85 9.85 7.27
CAN (%) 45 5.69 15.04 10.00 2.05
CRD (%) 45 4.70 13.47 8.23 2.34
NCD (%) 45 48.93 75.37 64.50 7.14

Results and discussion

Unit root test

Prior to testing for cointegration, we test the order of integration for each variable using the Augmented Dickey-Fuller (ADF) test. The unit root test equation for ADF is depicted as Δyt=a0+θyt1+γt+a1Δyt1+a2Δyt2++apΔytp+at where the joint null hypotheses are H0: θ = 0 (non-stationary) and H1: θ<0 (stationary). Although not required by the ARDL framework, we conduct the unit root tests to ensure that none of the variables are integrated of order two since that will make the provided critical values for bounds test invalid. As can be seen from Table 3, only chronic respiratory disease (CRD) and secondary school enrolment rate (SEC) are stationary at 5 percent at level form, whereas all other variables are stationary at first difference. Hence, the results indicate that the ARDL framework is the only appropriate method to analyse the long-run cointegration relationship rather than the Engle-Granger and the Johansen cointegration model.

Table 3. Unit root test.

Variable Lag length ADF-Statistics Critical Value Conclusion
lny 0 -2.54 -3.52 I(1)
Δlny 0 -8.95 -2.93 I(0)
lnk 1 -2.85 -3.52 I(1)
Δlnk 0 -5.74 -2.93 I(0)
NCD 7 -2.88 -3.54 I(1)
ΔNCD 4 -6.16 -2.94 I(0)
DM 0 -2.54 -3.52 I(1)
ΔDM 0 -6.94 -2.93 I(0)
CVD 0 -3.33 -3.52 I(1)
ΔCVD 1 -6.68 -2.93 I(0)
CRD 0 -6.66 -3.51 I(0)
ΔCRD 9 -3.99 -2.95 I(0)
CAN 1 -2.32 -3.52 I(1)
ΔCAN 0 -11.13 -2.93 I(0)
SEC 0 -3.40 -3.19 I(0)
ΔSEC 0 -7.77 -2.93 I(0)

The null hypothesis indicates that the series has a unit root problem. Up to 9 lags were tested and AIC was used to select the optimum number of lags. Variables at level form included both the intercept and trend, however, only intercept was included in the first difference equations. All unit root tests were conducted in EViews 10. Critical values for ADF-statistics are provided at a 5 percent significance level.

ARDL bounds test approach to cointegration

We use critical values provided by Narayan [31] for bounds test since the critical values provided by Pesaran, Shin [29] are based on large sample size, which is not appropriate for time-series studies involving small sample size. For model (4), the calculated F-statistic is higher than the upper bound critical value at 10 percent significance level and for model (5); the F-statistic is above the upper bound critical value at 5 percent significance level (Table 4). Hence, the null hypothesis of no cointegration is rejected and there exists a long-run cointegration relationship among the variables in both models. After establishing that a long-run cointegration relationship exists among the variables, we estimate each equation using the unrestricted error correction model. The maximum lag length was set at 4 in EViews and the optimum lag length was chosen using the Akaike Information Criterion (AIC).

Table 4. F-statistics for ARDL bounds test for cointegration.

Models Critical value bounds of the F-statistic Calculated F-Statistic
5% level 10% level
I(0) I(1) I(0) I(1)
(4) 3.08 4.02 2.56 3.43 3.56C (k = 3)
(5) 2.59 3.77 2.19 3.25 4.72B (k = 6)

A, B, C indicate significance at 1, 5 and 10 percent levels. The F-statistic values are compared to the critical values by Narayan [31]. k is the number of regressors.

Long-run and short-run results

After establishing that a long-run cointegration relationship exists among the variables, we estimated each equation using the unrestricted error correction model (UECM). We present the long-run and short-run empirical results for model (4) in Tables 5 and 6 respectively. The empirical results for model (5) are presented in Tables 7 and 8. Additionally, we included the standard diagnostic tests for each model alongside the short-run results.

Table 5. Long-run results of model (4), 1972–2016.

Variables (dependent is lny) Coefficients t-Statistic
Constant 6.586A 23.216
lnk 0.126 A 2.972
SEC 0.0022 A 6.417
NCD -0.012 A -2.840

A, B, C indicate significance at 1, 5 and 10 percent levels.

Table 6. Short-run results of model (4), 1972–2016.

Variables (dependent is Δlny) Coefficients t-Statistic
Δlnyt−1 0.303C 1.812
Δlnyt−2 0.451 A 3.400
Δlnyt−3 0.284B 2.207
ΔSECt 0.006B 2.067
ΔSECt−1 -0.008 A -3.146
ΔNCDt -0.005 A -2.934
ΔNCDt−1 0.005 A 3.483
ΔNCDt−2 0.006 A 4.230
COUP -0.075 A -3.228
ECTt−1 -0.698 A -4.417
Goodness of fit and diagnostic tests
Observations 45
χ2(sc)– Serial Correlation 0.705[0.504]
χ2(hs)—Heteroscedasticity 0.386[0.963]
χ2(ff)–Functional Form 0.864[0.361]
χ2(n)–Normality 1.598[0.450]

A, B, C indicate significance at 1, 5 and 10 percent levels. F-statistics represent diagnostic tests for serial correlation, heteroscedasticity and functional form while Jarque-Bera test statistic is shown for normality test. [] contains the p-values.

Table 7. Long-run results of model (5), 1972–2016.

Variables (dependent is lny) Coefficients t-Statistic
Constant 6.555A 13.029
lnk 0.300 A 4.404
SEC 0.0081 C 1.887
DM -0.010 A -3.003
CVD -0.018 A -3.665
CRD -0.031 C -1.911
CAN -0.035 A -4.212

A, B, C indicate significance at 1, 5 and 10 percent levels.

Table 8. Short-run results of model (5), 1972–2016.

Variables (dependent is Δlny) Coefficients t-Statistic
Δlnyt−1 0.204 C 1.842
Δlnyt−2 0.274 B 2.475
Δlnyt−3 0.343 A 2.991
Δlnkt -0.003 -0.051
ΔSECt 0.004 C 1.985
ΔSECt−1 -0.007 A -3.371
ΔSECt−2 0.003 C 2.063
ΔCVDt -0.009 A -5.313
ΔCVDt−1 0.005 A 3.740
ΔCVDt−2 0.005 A 4.263
ΔCRD -0.014 A -3.802
ΔCRDt−1 0.012 A 3.284
ΔCAN -0.0023 -0.882
ΔCANt−1 -0.020 A -5.976
ΔCANt−2 0.011 A 4.340
COUP -0.084 A -4.416
ΔECTt−1 -0.777 A -7.305
Goodness of fit and diagnostic tests
Observations 45
R2 0.808
R¯2 0.680
χ2(sc)–Serial Correlation 1.052[0.374]
χ2(hs)—Heteroscedasticity 0.480[0.949]
χ2(ff)–Functional Form 0.534[0.476]
χ2(n)–Normality 1.801[0.406]

A, B, C indicate significance at 1, 5 and 10 percent levels. F-statistics represent diagnostic tests for serial correlation, heteroscedasticity and functional form while Jarque-Bera test statistic is shown for normality test. [] contains the p-values.

Prior to interpreting the long-run and short-run results, we assess the model stability and validity of parameters using the standard diagnostic and stability tests. The error correction terms (ECTt−1) in the short-run UECM for models (4) and (5) are statistically significant at 1 percent level and have a negative sign, which confirms that a long-run cointegration relationship exists among the variables. The error correction coefficients are -0.698 for model (4) and -0.777 for model (5), which indicates that 69.8 percent and 77.7 percent of the disequilibrium in models (4) and (5) from past periods are corrected in the current period respectively. The overall goodness of fit for each model is also quite good, with the Adjusted-R squared values of 47 percent for model (4) and 68 percent for model (5). We found no evidence of serial correlation, heteroscedasticity, non-normality of errors and improper functional form in model (4) and model (5). In addition, Figs 1 and 2 show the cumulative sum of residuals (CUSUM) and cumulative sum of squared residuals (CUSUM of squares) stability test results for models (4) and (5), respectively, which are within the 5 percent critical bounds indicating both models are stable. Hence, the statistics for error correction term, diagnostic tests and model stability test confirm that the long-run and short-run coefficients are stable and indeed affect Fiji’s output per capita.

Fig 1. Model (4) CUSUM and CUSUM of squares test.

Fig 1

CUSUM and CUSUM of Squares are tests for model stability. At 5 percent significance level, the lines stay within the critical bounds, indicating long-run model stability.

Fig 2. Model (5) CUSUM and CUSUM of squares test.

Fig 2

CUSUM and CUSUM of Squares are tests for model stability. At 5 percent significance level, the lines stay within the critical bounds, indicating long-run model stability.

In the long-run, the coefficient of capital per worker (lnk) has a positive sign in models (4) and (5), but the parameter values are unstable. The elasticity of capital per capita is 0.126 in model (4) and 0.3 in model (5). The positive elasticity of capital is the result of a large investment in capital infrastructure and fixed capital formation. Over the years, government-related expenditure towards capital investment has increased which represents on average 30 percent of the total government expenditure [36]. In the short-run, capital per capita Δlnkt in model (5) is negative and statistically insignificant.

The education variable, secondary school enrolment rate (SECt) has the expected positive sign while being statistically significant at the 10 percent level in each model. The results imply that development of human capital is crucial for Fiji to increase the output per capita. With this in mind, the Government of Fiji has provided various scholarships and loans schemes to the students to develop the human capital capacity. The Government of Fiji has also made primary and secondary education free. Our results suggest that the current initiative by the Government of Fiji in terms of investment in education will significantly improve the output of Fiji in the future. In the short-run, ΔSECt has a positive sign and is statistically significant at the 10 percent level in both models. Meanwhile, ΔSECt−1 has a negative sign, while being statistically significant in both models. The negative coefficient implies that the benefits of education are not realised in the short-run since it takes many years to develop the human capital capacity.

In both models, the dummy variable (COUP) for political instabilities in years 1987, 2000 and 2006 had a negative sign and is strongly significant at 1 percent level in the short-run. The results indicate that coups negatively affect the output per capita of Fiji, which is consistent with the findings of Narayan and Smyth [35] and Chand [37].

Furthermore, the non-communicable disease mortality rate (NCDt) has the expected negative sign in the long-run and is statistically significant at 1 percent level in model (4). The negative sign implies that NCD-related mortality negatively affects the long-run output per capita since it causes death of workers in the working-age population of Fiji, which reduces the size of the skilled and unskilled labour force. In Fiji, NCDs represent more than 80 percent of the total mortality, of which most deaths are premature, that is, before the retirement age. A high rate of NCD-related deaths among the working age population also increases the years of productive life lost, which negatively affects the output per capita.

In the short-run, we found that ΔNCDt has a negative sign in model (4) and is statistically significant at 5 percent level. Meanwhile, ΔNCDt−1 and ΔNCDt−2 have a positive sign and are statistically significant at 5 percent level. Hence, the results imply that immediate NCD mortality reduces the output due to loss of skilled workers. However, past years’ NCD mortality rate has a positive sign, which indicates that firms are able to employ new workers to fill in vacant positions left by deceased workers and restore production in one to two years following the death of a worker.

Furthermore, we decomposed the aggregate NCD mortality rate into four major types of NCDs to measure the individual impact on output per capita. Diabetes (DM), cardiovascular diseases (CVD), chronic respiratory disease (CRD), and cancer (CAN) mortality rates have the expected negative sign in the long-run in model (5) (Table 7). The mortality rates of four major types of NCDs are also statistically significant at 10 percent significance level. Hence, we found that the aggregate NCD mortality rates, as well as the four major types of NCDs, have a deteriorating impact on the long-run output per capita of Fiji. We also found that in the short-run, ΔCVDt, ΔCRDt and ΔCANt−1 have a significant negative effect on the output per capita. However, ΔCVDt−1, ΔCVDt−2, ΔCRDt−1, and ΔCANt−2 have a significant positive effect on output, which suggests that firms are able to replace workers who died due to cardiovascular disease, chronic respiratory disease and cancer in one to two years following the death of a worker and able to restore the level of output.

The overall result of this study is in line with the theory of Suhrcke and Urban [19] and findings of Frank [23] where they argued that as NCD-related mortality become more common in the developing countries, it will start to negatively affect the long-run output per capita.

Robustness test

We re-estimated model (5) with additional control variables to check the robustness and consistency of the coefficients with the results presented in Table 9 (long-run) and Table 10 (short-run). Some of the important determinants of output in Fiji are trade openness [38], government expenditure [36], and inflation rate [39]. Hence, we added each control variable one at a time and estimated the model using the ARDL framework. Model (i) includes trade openness, which controls the supply and availability of healthy and unhealthy food products in the economy [40]. Trade openness captures bad nutrition habits that lead to the development of NCDs in the population. Furthermore, the government expenditure variable captures the role of government in providing funds for NCD-related preventative and curative services for the formulation of NCD strategic plans and free medicine schemes [41]. Lastly, the inflation rate captures the change in the price of nutritious and healthy food. We assume that as the price of nutritious and healthy foods increase, individuals will buy inexpensive processed foods as alternatives that potentially increase the risk of NCDs in the population [42].

Table 9. Effect of NCD mortality on output per capita–robustness test.

Variables (lnyt) Models
(i) (ii) (iii)
Added control variable Trade openness Government Expenditure Inflation Rate
constant 6.103 A (10.661) 6.734 A (14.406) 4.321 A (404)
lnkt 0.289 A (4.399) 0.263 A (4.208) 0.511 A (4.033)
DMt -0.011 A (-3.134) -0.009 A (-3.302) -0.019 A (-3.548)
CVDt -0.022 A (-3.058) -0.015 A (-3.349) -0.031 A (-3.932)
CRDt -0.037 C (-1.944) -0.030 B (-2.113) -0.026 C (-1.784)
CANt -0.038 A (-4.012) -0.036 A (-4.811) -0.042 A (-5.056)
SECt 0.0070 (1.502) 0.0079 C (2.065) 0.0090 C (2.007)
OPENt 0.001 (1.018) - -
GOVt - 0.006 (1.241) -
INFt - - -0.005 (-1.627)

A, B, C indicate significance at 1, 5 and 10 percent levels.

Table 10. Error correction representations for the selected ARDL model–robustness test.

Variables (Δlnyt) Models
(i) (iii) (iv)
Added control variable Trade openness Government Expenditure Inflation Rate
Δlnyt−1 0.160 (1.506) 0.206 C (1.902) 0.330 A (2.911)
Δlnyt−2 0.153 (1.337) 0.262 B (2.458) -
Δlnyt−3 0.300 A (2.662) 0.350 A (3.168) -
Δlnkt -0.046 (-0.920) -0.003 (-0.052) 0.008 (0.175)
Δlnkt−1 - - -0.110 C (-1.809)
Δlnkt−2 - - -0.281 A (-3.999)
ΔDMt - - -0.010 A (-4.790)
ΔCVDt -0.010 A (-5.938) -0.009 A (-556) -0.012 A (-6.989)
ΔCVDt−1 0.007 A (4.753) 0.004 A (3.354) 0.009 A (576)
ΔCVDt−2 0.006 A (5.045) 0.004 A (3.716) 0.007 A (6.260)
ΔCRDt -0.015 A (-4.308) -0.014 A (4.050) -0.007 C (-2.019)
ΔCRDt−1 0.016 A (4.166) 0.012 A (3.548) 0.013 A (3.962)
ΔCANt -0.002 (-0.835) -0.003 (-1.143) 0.0002 (0.076)
ΔCANt−1 0.021 A (6.285) 0.022 A (6.546) 0.022 A (6.307)
ΔCANt−2 0.010 A (4.299) 0.012 A (4.868) 0.011 A (4.454)
ΔSECt 0.003 (1.596) 0.004 C (2.046) 0.008 A (4.525)
ΔSECt−1 -0.007 A (-3.573) -0.007 A (-3.800) -0.003 C (-2.018)
ΔSECt−2 0.005 A (2.826) 0.003 C (1.725) 0.006 A (3.958)
ΔOPENt -0.0004 (-0.925) - -
COUP -0.075 A (-4.141) -0.085 A (-4.638) -0.110 A (-5.308)
ECTt−1 -0.805 A (-7.704) -0.874 A (-7.729) -0.687 A (-7.727)
Goodness of Fit and diagnostic tests
R¯2 0.704 0.704 0.716
Standard Error 0.023 0.023 0.022
χ2(sc)–Serial Correlation 0.636 [0.545] 0.876 [0.438] 0.071 [0.932]
χ2(hs)—Heteroscedasticity 2.418 [0.033] 0.547 [0.912] 0.521 [0.930]
χ2(ff)–Functional Form 0.156 [0.699] 2.642 [0.125] 0.604 [0.449]
χ2(n)—Normality 1.064 [0.588] 1.918 [0.383] 2.024 [0.364]
Bounds test 4.301 B 4.425 B 4.422 A

A, B, C indicate significance at 1, 5 and 10 percent levels. F-statistics represent diagnostic tests for serial correlation, heteroscedasticity and functional form while Jarque-Bera test statistic is shown for normality test. [] contains the p-values.

Overall, we find that the four major types of NCD mortality rates have the expected negative sign and are significant at the 10 percent level. The coefficients of diabetes, cardiovascular disease, chronic respiratory disease and cancer mortality rates are significant and moderately higher than the long-run estimates of model (5).

The inclusion of trade openness (OPENt), and government expenditure (GOVt) as additional variables in models (i) and (ii) show very little fluctuations in the coefficients of diabetes, cardiovascular disease, chronic respiratory disease and cancer mortality rates. The only difference being that SEC became weakly insignificant in model (i). The largest fluctuation in the coefficient value is noticed when the inflation rate (INFt) was added as an additional variable in model (iii). However, the coefficients of trade openness, government expenditure, and inflation rate were highly insignificant despite having the expected sign.

Hence, the robustness test shows the impact range of four major types of NCD mortality rates on the level of output per capita. On average, the coefficient of diabetes (DM) ranges from -0.009 to -0.019, cardiovascular disease (CVD) ranges from -0.015 to -0.031, chronic respiratory disease (CRD) ranges from -0.026 to -0.037 and cancer (CAN) ranges from -0.033 to -0.042. Hence, diabetes, cardiovascular disease, chronic respiratory disease and cancer mortality lowered Fiji’s output per capita from 1972 to 2016 and the effects will be heavier in future when the number of NCD deaths rise.

The coefficients of the error correction terms were -0.81, -0.87 and -0.69 for models (i), (ii) and (iii) respectively, which suggests that convergence to equilibrium was rapid. The Adjusted-R squared also improved by an average of 2.4 to 3.6 percent. In addition, the models passed the diagnostic tests for serial correlation, heteroscedasticity, normality and functional form, except for model (i) that failed to pass the test for heteroscedasticity. However, it is common to find the problem of heteroscedasticity in the ARDL framework since the models use variables that are both integrated of order zero and order one [33].

Conclusion and policy implications

The ARDL bounds test confirmed that there exists a long-run cointegration relationship among the variables when output per capita is the dependent variable, while capital per worker, secondary schooling and mortality rates for diabetes, cardiovascular disease, chronic respiratory disease, cancer and NCDs are the independent in models (4) and (5). In model (4), capital per worker and secondary schooling have a positive sign while NCD mortality rate has the expected significant negative sign. In model (5), diabetes, cardiovascular disease, chronic respiratory disease and cancer mortality rates had a significant negative effect on the long-run output per capita. The robustness test also confirmed that the parameters remain consistent in terms of signs across different scenarios. Afterwards, the error correction model was estimated to derive the short-run relationship. The negative and highly significant error correction term also confirmed a long-run relationship among the variables and the convergence towards the steady state was quick.

The empirical studies on the relationship between NCD mortality rate and output per capita have shown mixed results. According to Suhrcke and Urban [19], CVD mortality rate negatively affects the output of developed countries, while there exists a positive relationship between CVD mortality rate and output in developing countries. Our results contradict Suhrcke and Urban [19] since we found that NCD mortality rates have a significant negative effect on the output of Fiji, which is a developing country. On a similar note, Frank [23] also found that NCD mortality negatively affects output in Latin America and the Caribbean countries. Hence, based on the results of this study and Frank (2014), we conclude that NCD mortality rates have begun to negatively affect the output per capita of developing countries.

The study has several limitations; hence, the results of this should be used and interpreted cautiously. Firstly, the study uses the NCD mortality rate as a proxy to measure the impact of the non-communicable diseases on Fiji’s output per capita due to the lack of data on NCD morbidity, disability, prevalence and incidence rate in Fiji. Secondly, we were not able to test the robustness of the results using other cointegration techniques apart from the ARDL bounds test approach since the variables of interest were integrated of both order zero and one. Thirdly, the study measures the impact of NCD mortality rate on the long-run output per capita of Fiji and not the economic growth. Factor accumulation, human capital and NCD mortality rates were only able to explain 70 to 80 percent of the variation in output per capita, hence, to get an in-depth view on the impact of NCD mortality on output per capita of Fiji, additional explanatory variables will need to be augmented in the model.

Overall, our finding have important policy implication for Fiji. Policy makers should make serious effort to lower NCD related fertility rate in Fiji. This necessitates measures such as multi-sectoral collaboration and collective response from various organisations such as households, businesses, NGOs and the government. Individuals can prevent the indirect cost of NCD-related mortality by changing lifestyle behaviour. A healthy diet, taking part in physical activities as well as avoiding the consumption of alcohol and tobacco are best remedies that individuals can practise to avoid the risk of NCDs.

Similarly, the Fijian Government should extensively fund the NCD preventative agenda instead of just in NCD curative areas. According to a policy brief from Ministry of Health and Medical Services [43], Government allocated fund are usually larger for curative purposes compared to preventative purposes. The NCD preventative policy should focus on providing education on lifestyle diseases, impose subsidy on healthy foods and tax the harmful foods, tobacco and alcohol. Physical activity should be highly encouraged among adults and ensure compulsory participation in physical activities in schools. These initiatives are necessary on households and government’s part to reduce the risk of contracting NCDs and its negative implications on the economy.

Businesses should maintain a certain requirement of healthy living and engagement in physical activity among the employees since it increase business expenditure for employee healthcare and coverage at the firm level [44]. Although it requires some investment, in the long-run healthy and skilled workers will improve the level of output and productivity. This will also reduce the cost of training and developing workers to fill the gap left by deceased or absent worker suffering from NCDs.

Supporting information

S1 Data

(XLSX)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.World Health Organization. Preventing chronic diseases: a vital investment. Ganeva: World Health Organization; 2005. [Google Scholar]
  • 2.World Health Organization. Noncommunicable diseases 2018 [Available from: http://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
  • 3.Alleyne G, Basu S, Stuckler D. Who's afraid of noncommunicable diseases? Raising awareness of the effects of noncommunicable diseases on global health. Journal of Health Communication. 2011;16(2):82–93. [DOI] [PubMed] [Google Scholar]
  • 4.Bloom D, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom L, Fathima S. The Global Economic Burden of Noncommunicable Diseases. Ganeva: World Economic Forum; 2011. [Google Scholar]
  • 5.Ministry of Health and Medical Services. Annual Report 2015. Suva: Fiji Ministry of Health and Medical Services; 2016. 96 p.
  • 6.World Health Organization. Noncommunicable Diseases Progress Monitor 2017. Ganeva: World Health Organization; 2017. 231 p. [Google Scholar]
  • 7.Meyer J. Diabetes deaths in Fiji worst in the world, says watchdog 2018 [Available from: https://asiapacificreport.nz/2018/05/30/diabetes-deaths-in-fiji-worst-in-the-world-says-report/.
  • 8.Maharaj JC, Reddy M. Young stroke mortality in Fiji Islands: An economic analysis of national human capital resource loss. ISRN neurology. 2012;2012:1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Heenan RC, Bärnighausen T, O'Brien J, Parks T, Kado JH, Bloom D, et al. O114 The cost-of-illness of rheumatic heart disease: a national estimation in Fiji. Global Heart. 2014;1(9):30–1. [Google Scholar]
  • 10.Abegunde D, Stanciole A. An estimation of the economic impact of chronic noncommunicable diseases in selected countries. World Health Organization, Department of Chronic Diseases and Health Promotion. 2006;2006. [Google Scholar]
  • 11.Bloom D, Cafiero-Fonseca E, McGovern M, Prettner K, Stanciole A, Weiss J, et al. The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons. The Journal of the Economics of Ageing. 2014;4:100–11. [Google Scholar]
  • 12.Bloom D, Chen S, McGovern M. The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and Peru. Revista Panamericana de Salud Pública. 2018;42(18):1–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Abegunde D, Mathers C, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. The Lancet. 2007;370(9603):1929–38. [DOI] [PubMed] [Google Scholar]
  • 14.Kirigia JM, Mwabu GM, M'Imunya JM, Muthuri RDK, Nkanata LHK, Gitonga EB. Indirect cost of non-communicable diseases deaths in the World Health Organization African Region. International Archives of Medicine. 2017;10(34):1–21. [Google Scholar]
  • 15.Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–37. 10.3350/cmh.2014.20.4.327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLOS ONE. 2011;6(10):1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, Marianna de Camargo C, et al. Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China, and South Africa (BRICS): A population-based comparison. Cancer Epidemiology. 2018;53(2018):27–34. [DOI] [PubMed] [Google Scholar]
  • 18.Hanly P, Soerjomataram I, Sharp L. Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer-related mortality in Europe. International Journal of Cancer. 2015;136(4):136–45. [DOI] [PubMed] [Google Scholar]
  • 19.Suhrcke M, Urban D. Are cardiovascular diseases bad for economic growth? Health Economics. 2010;19(12):1478–96. 10.1002/hec.1565 [DOI] [PubMed] [Google Scholar]
  • 20.Weil DN. Health and economic growth. Handbook of Economic Growth. 2: Elsevier; 2014. p. 623–82. [Google Scholar]
  • 21.Neeliah H, Shankar B. Is nutritional improvement a cause or a consequence of economic growth? Evidence from Mauritius. Economics Bulletin. 2008;17(8):1–11. [Google Scholar]
  • 22.Dube W, Phiri A. Nutrition and economic growth in South Africa: a threshold co-integration approach. Journal of Economic Studies. 2015;42(1):138–56. [Google Scholar]
  • 23.Frank L. Too sick to progress? Economic impacts of non-communicable diseases in Latin America and the Caribbean. Suva: The University of the South Pacific; 2014. [Google Scholar]
  • 24.Bloom D, Canning D, Sevilla J. The effect of health on economic growth: a production function approach. World Development. 2004;32(1):1–13. [Google Scholar]
  • 25.Barro R. Economic growth in a cross section of countries. The Quarterly Journal of Economics. 1991;106(2):407–43. [Google Scholar]
  • 26.Granger CW. Some properties of time series data and their use in econometric model specification. Journal of Econometrics. 1981;16(1):121–30. [Google Scholar]
  • 27.Engle RF, Granger CW. Co-integration and error correction: representation, estimation, and testing. Econometrica: Journal of the Econometric Society. 1987;55(2):251–76. [Google Scholar]
  • 28.Pesaran MH, Shin Y. An autoregressive distributed-lag modelling approach to cointegration analysis. Econometric Society Monographs. 1998;31:371–413. [Google Scholar]
  • 29.Pesaran MH, Shin Y, Smith RJ. Bounds testing approaches to the analysis of level relationships. Journal of Applied Econometrics. 2001;16(3):289–326. [Google Scholar]
  • 30.Johansen S, Juselius K. Maximum likelihood estimation and inference on cointegration—with applications to the demand for money. Oxford Bulletin of Economics and Statistics. 1990;52(2):169–210. [Google Scholar]
  • 31.Narayan P. The saving and investment nexus for China: evidence from cointegration tests. Applied Economics. 2005;37(17):1979–90. [Google Scholar]
  • 32.Rahman MM, Kashem MA. Carbon emissions, energy consumption and industrial growth in Bangladesh: Empirical evidence from ARDL cointegration and Granger causality analysis. Energy Policy. 2017;110(2017):600–8. [Google Scholar]
  • 33.Samargandi N, Fidrmuc J, Ghosh S. Financial development and economic growth in an oil-rich economy: The case of Saudi Arabia. Economic Modelling. 2014;43(2014):267–78. [Google Scholar]
  • 34.Murthy VNR, Okunade AA. Determinants of U.S. health expenditure: Evidence from autoregressive distributed lag (ARDL) approach to cointegration. Economic Modelling. 2016;59(2016):67–73. [Google Scholar]
  • 35.Narayan P, Smyth R. Trade liberalization and economic growth in Fiji. An empirical assessment using the ARDL approach. Journal of the Asia Pacific Economy. 2005;10(1):96–115. [Google Scholar]
  • 36.Narayan P, Prasad A, Singh B. A test of the Wagner's hypothesis for the Fiji islands. Applied Economics. 2008;40(21):2793–801. [Google Scholar]
  • 37.Chand S. Swim or sink: The post-coup economy in limbo. In: Fraenkel J, Firth S, Lal BV, editors. The 2006 Military Takeover in Fjii: A Coup to End All Coups?: ANU Press; 2009. p. 139–53. [Google Scholar]
  • 38.Rao BB, Rao M. Openness and growth in Fiji: some time series evidence. Applied Economics. 2009;41(13):1653–62. [Google Scholar]
  • 39.Gokal V, Hanif S. Relationship between inflation and economic growth. Suva: Economics Department, Reserve Bank of Fiji; 2004. [Google Scholar]
  • 40.Labonté R, Mohindra KS, Lencucha R. Framing international trade and chronic disease. Globalization and Health. 2011;7(21):1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Anderson I. The economic costs of noncommunicable diseases in the Pacific Islands: a rapid stocktake of the situation in Samoa, Tonga, and Vanuatu. NHP Discussion Paper 2013.
  • 42.Eyles H, Ni Mhurchu C, Nghiem N, Blakely T. Food pricing strategies, population diets, and non-communicable disease: a systematic review of simulation studies. PLoS Med. 2012;9(12):1–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ministry of Health and Medical Services. NCD Persists—more money or better management. Suva: Fiji Ministry of Health and Medical Services; 2014. [Google Scholar]
  • 44.Adams C. Why Non-Communicable Diseases Matter to Business: Interview with Cary Adams. In: Health GBC, editor. Union for International Cancer Control and NCD Alliance 2013. [Google Scholar]

Decision Letter 0

Gausal A Khan

20 May 2020

PONE-D-20-10474

Non-Communicable disease mortality in Small Pacific Island Countries: Estimating the loss of human capital resource

PLOS ONE

Dear Dr. Singh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jul 04 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Gausal A Khan, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure you have thoroughly discussed any potential limitations of this study within the Discussion section.

Additional Editor Comments (if provided):

Dear Author.

Please go though the reviewers comments and point-to-point reply will submit for further evaluation.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Results have to organised in a better way and figures should be more presentable. Discussion should be brief and to the point. Conclusion does not reflect discussion, it should be rewritten. Some of the references are not organised properly.

Reviewer #2: Health economics is a growing field that push the universal health coverage agenda forward for improving health coverage, expanding services, and providing financial-risk protection are all necessary to optimize the population health. Chronic non-communicable disease (NCD) is the big issue in low and middle income countries which really need to focus on the building health systems that integrate complex, multidisciplinary interventions to reduce the economical burden.

This study is focused on estimate the net percentage value loss of non-health GDP, and indirect cost of Non-communicable disease related mortality among the working age group of eight small Pacific Island countries (PIC) in 2017.Using human capital approach methodology with non-health GDP per capita, author emphasize that NCD related premature death in working age population creates a potential economical burden for the PICs.

In most of the countries, the premature mortality due to cardiovascular disease and in working ages from 15 until the retirement age. Also, this study has recommended intervention to reduce the prevalence of NCD related that all small PICs should reduce the prevalence of NCD related premature death.

This manuscript well written and describe the economical burden for the small Pacific Islands countries and also the interventions to reduce.

The following comments should be resolved:

(1) Which statistical analysis was used in this study to claim that NCD-related death in the working age group create a significant economic burden in the PIC?

(2) Figure 1, bar diagram shows that percentage of total death is increased in NCD group in different group, but it is not clear that it is significant or not as no statistical analysis was shown.

(3) Same in case of figure 3.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Jul 23;15(7):e0236068. doi: 10.1371/journal.pone.0236068.r002

Author response to Decision Letter 0


18 Jun 2020

Response to Reviewers

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Response: We have revised the methodology and the methods used that are technically sound. We have used the Autoregressive Distributed Lag (ARDL) bounds test to cointegration approach to draw our conclusion. We have used official secondary data which is compiled by Ministry of Health, Fiji and the World Health Organization. Sample used is appropriate and bounds test to cointegration is standard procedure used to analyse time series data. Revised manuscript is based on Fiji as there no data available for other Pacific Island countries. Revised manuscript is based on long time series data which is only available for Fiji.

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: No

Response: We have revised the methodology. We have used bounds test to cointegration approach. One of the advantages of the ARDL model is that it is very flexible where variables of both I(0) and I(1) status can be used to test for a cointegrating relationship. Secondly, the ARDL approach is an advantage to studies using a small sample size for estimation and forecasting [29]. Thirdly, the ARDL approach gives a consistent and unbiased estimate of the long-run parameters and each variable can have their own different lag-lengths compared to conventional cointegration tests. The fourth advantage of the ARDL approach is that it adequately deals with the problems of autocorrelation and endogeneity and provides unbiased and super-consistent coefficients with valid t-statistics. In sum, there are two steps involved in the ARDL bounds test approach to cointegration. We performed a number of robustness test and found our result is consistent. We carried out several diagnostic test and our result suffice all classical assumption.

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

Response: We have uploaded all the data used in the analysis.

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Response: Manuscript presented and written in standard English.

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Results have to organised in a better way and figures should be more presentable. Discussion should be brief and to the point. Conclusion does not reflect discussion, it should be rewritten. Some of the references are not organised properly.

Response: We have rewritten all our results and discussion. Now it is more presentable, clear and easy to follow. We have rewritten our conclusion and policy implications and now it reflects the findings and discussion.

Reviewer #2: Health economics is a growing field that push the universal health coverage agenda forward for improving health coverage, expanding services, and providing financial-risk protection are all necessary to optimize the population health. Chronic non-communicable disease (NCD) is the big issue in low and middle income countries which really need to focus on the building health systems that integrate complex, multidisciplinary interventions to reduce the economical burden.

This study is focused on estimate the net percentage value loss of non-health GDP, and indirect cost of Non-communicable disease related mortality among the working age group of eight small Pacific Island countries (PIC) in 2017.Using human capital approach methodology with non-health GDP per capita, author emphasize that NCD related premature death in working age population creates a potential economical burden for the PICs.

In most of the countries, the premature mortality due to cardiovascular disease and in working ages from 15 until the retirement age. Also, this study has recommended intervention to reduce the prevalence of NCD related that all small PICs should reduce the prevalence of NCD related premature death.

This manuscript well written and describe the economical burden for the small Pacific Islands countries and also the interventions to reduce.

The following comments should be resolved:

(1) Which statistical analysis was used in this study to claim that NCD-related death in the working age group create a significant economic burden in the PIC?

Response: Our revised manuscript is extensively rewritten based on the comments and suggestion of two reviewers. In the revised manuscript, we have used bounds test to cointegration approach, it is standard procedure used to analyse factors affecting economic output. We carried out a several robustness test and find out result is consistent. Revised manuscript is based on Fiji as there no data available for other Pacific Island countries. Revised manuscript is based on long time series data which is only available for Fiji.

(2) Figure 1, bar diagram shows that percentage of total death is increased in NCD group in different group, but it is not clear that it is significant or not as no statistical analysis was shown.

Response: All results and graph figures are revised based on our revised findings. We have used ARDL bounds test to analyse our data. We carried out a number of diagnostic test and find our result is reliable.

(3) Same in case of figure 3.

Response: All our analysis is based on ARDL bounds testing technique. However, this comment is no longer relevant in revised manuscript.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Gausal A Khan

29 Jun 2020

The economic burden of non-communicable disease mortality in the South Pacific: Evidence from Fiji

PONE-D-20-10474R1

Dear Dr. Singh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gausal A Khan, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors responded to the comments made by the reviewer. The results should be described in the simplified manner. Reference need to be corrected.

Reviewer #2: This study is interesting and valuable regarding the economic burden and non-communicable disease mortality in the south Pacific, especially Fiji. The revised manuscript described well about the methods and statistical analysis based on comments and explains the analysis of the data. I am fully recommending this revised manuscript for publication. I hope, this publication opens a new sight to think about the economic burden and non-communicable related mortality rate in other countries.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Gausal A Khan

6 Jul 2020

PONE-D-20-10474R1

The economic burden of non-communicable disease mortality in the South Pacific: Evidence from Fiji

Dear Dr. Singh:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gausal A Khan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES